Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments
For years, researchers have been hopeful they could get under the hood of multiple sclerosis. The neurological condition shows up in over 2.5 million people around the world, but it doesn’t always look the same. If science could point its light in just the right way, patients might be sorted into disease subgroups, and treated more successfully depending on their kind of MS.
A new study out of Germany gives it a shot, offering up three MS subtypes based on immune markers found in patients’ blood — each group with slightly different disease progression.
